Skip to main content
Top

Drugs

Issue 3/2021

Content (9 Articles)

Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?

Shahini Shah, Laura Hindley, Andrew Hill

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

C. Louwrens Braal, Elisabeth M. Jongbloed, Saskia M. Wilting, Ron H. J. Mathijssen, Stijn L. W. Koolen, Agnes Jager

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G. Feagan

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review

C. A. J. Michielsens, M. E. van Muijen, L. M. Verhoef, J. M. P. A. van den Reek, E. M. G. J de Jong

Amisulpride: A Review in Post-Operative Nausea and Vomiting

Connie Kang, Matt Shirley

Inclisiran: First Approval

  • Open Access
  • AdisInsight Report

Yvette N. Lamb

Setmelanotide: First Approval

Anthony Markham

Berotralstat: First Approval

Arnold Lee

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images